During DIA’s Annual Meeting, June 18-22, in Chicago, the UBC team met hundreds of like-minded professionals, across dozens of disciplines, all focused on the goal of gaining and sharing knowledge to improve healthcare. We know that when we improve the quality of our work, we in turn improve patient access to life-changing and life-saving therapies.
On February 28, rare-disease communities around the world come together to advocate for an increase in research focused on rare diseases. When it comes to clinical research for rare and orphan diseases, the relationship with the patient and advocacy groups is critical to success.
In global clinical trials, sponsors must adhere to strict regulatory requirements, in multiple countries and cultures - during all phases of development - while meeting important deadlines. With thousands of oncology treatments in the pipeline, the competitive landscape can be a significant challenge to sponsors.
Access to clinical trial information is driving more participation by volunteers, not just patients. This shift is also shining a light on the evolving motivations of clinical trial participants.
This year Partnerships in Clinical Trials Europe is bringing together clinical development outsourcing professionals to discuss “The era of change: A panoramic vision of reform, challenge and innovation in clinical trials.” With services that span Clinical Development, Late Stage Research and Safety, UBC is uniquely positioned to add our voice to the conversation.
When recruiting Alzheimer’s patients for research studies, you’re recruiting caregivers as well. In our latest blog post, we share a few strategies that have worked for our clients.
Any good scientist should know that in order to keep up, you must constantly evolve your techniques. That’s especially true in the realm of clinical development, where balancing the challenges of patient-centric clinical trials with increasingly tighter budgets and shorter timelines is paramount to success.
UBC’s experts are here to help. In our free whitepaper, “Nine Evolutions in Clinical Research & Patient Recruitment: A 2016 Preview,” we share an in-depth look at the trends driving clinical trial participation.
The LAB is where experts from UBC join others from the entire family of Express Scripts Companies to solve for the most pressing pain points in healthcare today. We are working together on projects that span the entire pharma product life cycle. Contact us to request a visit to the LAB.
Today patient communities around the world will recognize World MS Day to raise awareness about multiple sclerosis and the impact it has on patients’ lives. In support of World MS Day, we asked a few of our experts how their work helps patients be #strongerthanMS.
Multiple sclerosis affects more than 2.3 million people worldwide and there is currently no approved cure. The pharmaceutical industry has been successful in creating treatment options to modify and manage the disease, but there is still a need for new and improved MS drugs.